Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for LXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -1.023M
March 31, 2026 -96.60M
December 31, 2025 -0.073M
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.103M
September 30, 2024 0.01M
June 30, 2024 0.014M
March 31, 2024 -239.78M
December 31, 2023 0.00
September 30, 2023 0.211M
June 30, 2023 -139.03M
March 31, 2023 0.824M
December 31, 2022 0.063M
September 30, 2022 -94.27M
June 30, 2022 0.00
March 31, 2022 0.864M
December 31, 2021 -0.379M
September 30, 2021 -19.78M
June 30, 2021 0.023M
March 31, 2021 -14.27M
December 31, 2020 -69.97M
September 30, 2020 0.00
June 30, 2020 0.103M
Date Value
March 31, 2020 0.923M
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.941M
December 31, 2018 -0.182M
September 30, 2018 -0.158M
June 30, 2018 -0.367M
March 31, 2018 0.947M
December 31, 2017 -2.506M
September 30, 2017 -0.054M
June 30, 2017 -4.316M
March 31, 2017 0.568M
December 31, 2016 -0.681M
September 30, 2016 -2.191M
June 30, 2016 -0.568M
March 31, 2016 0.437M
December 31, 2015 0.00
September 30, 2015 -0.114M
June 30, 2015 0.00
March 31, 2015 0.357M
December 31, 2014 -201.94M
September 30, 2014 -0.163M
June 30, 2014 -0.086M
March 31, 2014 0.811M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 149.30M
Pfizer Inc. 0.00
ANI Pharmaceuticals, Inc. 0.505M
Corcept Therapeutics, Inc. -9.42M
Veru, Inc. -0.001M